Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74:1220–33.
Zito PM, Scharf R. Keratoacanthoma. StatPearls; 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK499931/. Accessed 10 Feb 2024.
Tisack A, Fotouhi A, Fidai C, Friedman BJ, Ozog D, Veenstra J. A clinical and biological review of keratoacanthoma. Br J Dermatol. 2021;185:487–98.
Article CAS PubMed Google Scholar
Que SKT, Compton LA, Schmults CD. Eruptive squamous atypia (also known as eruptive keratoacanthoma): definition of the disease entity and successful management via intralesional 5-fluorouracil. J Am Acad Dermatol. 2019;81:111–22.
Article CAS PubMed Google Scholar
Cohen PR, Kurzrock R. Germline testing of mismatch repair genes is needed in the initial evaluation of patients with Muir-Torre syndrome-associated cutaneous sebaceous neoplasms: a case Series. Cureus. 2023;15: e33975.
PubMed PubMed Central Google Scholar
Martens MC, Emmert S, Boeckmann L. Xeroderma pigmentosum: gene variants and splice variants. Genes (Basel). 2021;12:1173.
Article CAS PubMed Google Scholar
Goudie D. Multiple self-healing squamous epithelioma (MSSE): a digenic trait associated with loss of function mutations in TGFBR1 and variants at a second linked locus on the long arm of chromosome 9. Genes (Basel). 2020;11:1–12.
Zhong FL, Mamaï O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell. 2016;167:187-202.e17.
Article CAS PubMed Google Scholar
Agarwal M, Chander R, Karmakar S, Walia R. Multiple familial keratoacanthoma of Witten and Zak—a report of three siblings. Dermatology. 1999;198:396–9. https://doi.org/10.1159/000018157.
Article CAS PubMed Google Scholar
Muir EG, Bell AJY, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg. 1967;54:191–5. https://doi.org/10.1002/bjs.1800540309.
Article CAS PubMed Google Scholar
Torre D. New York dermatological society. Arch Dermatol. 1968;98:549–52.
Article CAS PubMed Google Scholar
Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, et al. Appropriate use criteria in dermatopathology: initial recommendations from the American Society of Dermatopathology. J Am Acad Dermatol. 2019;80:189-207.e11.
John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016;74:558–66.
Cerretelli G, Ager A, Arends MJ, Frayling IM. Molecular pathology of Lynch syndrome. J Pathol. 2020;250:518–31.
Ferreira I, Wiedemeyer K, Demetter P, Adams DJ, Arends MJ, Brenn T. Update on the pathology, genetics and somatic landscape of sebaceous tumours. Histopathology. 2019;76:640–9.
Zhong CS, Horiguchi M, Uno H, Ukaegbu C, Chittenden A, LeBoeuf NR, et al. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. J Am Acad Dermatol. 2023;88:1282–90.
Aziz S, O’Sullivan H, Heelan K, Alam A, McVeigh TP. Characterization of sebaceous and non-sebaceous cutaneous manifestations in patients with lynch syndrome: a systematic review. Fam Cancer. 2023;22:167.
Article CAS PubMed Google Scholar
Cini G, Carnevali I, Sahnane N, Chiaravalli AM, Dell’Elice A, Maestro R, et al. Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene. Cancer Genet. 2021;254–255:1–10.
Cino D, Drumm C, Sheahan K, D’Arcy C, Nolan N, Hoti E, et al. Muir-Torre syndrome: a case of unusual coexisting genetic mutations. Clin Exp Dermatol. 2022;47:602–4. https://doi.org/10.1111/ced.15008.
Article CAS PubMed Google Scholar
Zhang R, Bhate C, Cai D. Genetic heterogeneity in a patient with Muir-Torre syndrome. JAAD Case Rep. 2020;6:886.
Article PubMed PubMed Central Google Scholar
Takayama E, Yoshioka A, Takai T, Goto K. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type. J Dermatol. 2021;48:690–4. https://doi.org/10.1111/1346-8138.15772.
Article CAS PubMed Google Scholar
Kacerovska D, Drlik L, Slezakova L, Michal M, Stehlik J, Sedivcova M, et al. Cutaneous sebaceous lesions in a patient with MUTYH-associated polyposis mimicking Muir-Torre Syndrome. Am J Dermatopathol. 2016;38:915–23.
Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med. 2014;16:711–6.
Smith JF. A case of multiple primary squamous-celled carcinomata of the skin in a young man, with spontaneous healing. Br J Dermatol. 1934;46:267–72. https://doi.org/10.1111/j.1365-2133.1934.tb09778.x.
Ferguson-Smith M, Goudie D. Orphanet—multiple self-healing squamous epithelioma; 2015. Available from https://www.orpha.net/en/disease/detail/65748. Accessed 20 Sept 2024.
Ferguson-Smith MA, Wallace DC, James ZH, Renwick JH. Multiple self-healing squamous epithelioma. Birth Defects Orig Artic Ser. 1971;7:157–63.
Saleh K, Gebre-Medhin S, Christensen G. Pancreatic cancer occurrence in Ferguson-Smith syndrome. JAAD Case Rep. 2018;4:565.
Article PubMed PubMed Central Google Scholar
Litaiem N, Khammouma F, Mrad M, Bacha T, Kacem LB, Zeglaoui F. Multiple keratoacanthomas of Ferguson-Smith type. Clin Case Rep. 2022;10: e06429. https://doi.org/10.1002/ccr3.6429.
Article PubMed PubMed Central Google Scholar
Kato N, Ito K, Kimura K, Shibata M. Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. J Am Acad Dermatol. 2003;49:741–6.
Article CAS PubMed Google Scholar
Goudie DR, D’Alessandro M, Merriman B, Lee H, Szeverényi I, Avery S, et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet. 2011;43:365–9.
Article CAS PubMed Google Scholar
Ferguson-Smith MA, Goudie DR. Digenic/multilocus aetiology of multiple self-healing squamous epithelioma (Ferguson-Smith disease): TGFBR1 and a second linked locus. Int J Biochem Cell Biol. 2014;53:520–5.
Article CAS PubMed Google Scholar
Chung Kang H, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D’Alessandro M, et al. Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology. J Invest Dermatol. 2013;133:1907.
Derynck R, Turley SJ, Akhurst RJ. TGF-β biology in cancer progression and tumor immunotherapy. Nat Rev Clin Oncol. 2021;18:9.
Yang Y, Ye WL, Zhang RN, He XS, Wang JR, Liu YX, et al. The role of TGF-β signaling pathways in cancer and its potential as a therapeutic target. Evid Based Complement Alternat Med. 2021;2021:6675208.
PubMed PubMed Central Google Scholar
Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A. TGF1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 1996;86:531–42.
留言 (0)